Tetrahydrobiopterin Supplementation Protects Retinal Ganglion Cells Against NMDA-Induced Excitotoxicity Through nNOS-Coupled Nitric Oxide Signaling
Investigative Ophthalmology & Visual Science · 2026-11-12 · 67 (13) · 19
DOI: 10.1167/iovs.67.13.19 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, published on 2026-11-12. Written by Weizhou Fang and 7 co-authors. Institution: Eye Center of Xiangya Hospital, Central South University, Changsha, Hunan, China. Major MEDLINE topics: Retinal Ganglion Cells, N-Methylaspartate, Nitric Oxide, Biopterins. 54 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
Excitotoxic injury triggered by excessive N-methyl-d-aspartate (NMDA) receptor activation represents an important mechanism underlying retinal neurodegeneration in glaucoma. Tetrahydrobiopterin (BH4), an essential cofactor for nitric oxide synthase (NOS), exhibits neuroprotective potential in multiple neurodegenerative diseases, but its role in retinal ganglion cells (RGCs) under excitotoxic injury remains unclear. This study assessed the neuroprotective effects of BH4 against excitotoxic retinal injury and explored its underlying mechanisms.
Methods
Glutamate-treated R28 cells and intravitreal NMDA-injected rat retinas were used as in vitro and in vivo excitotoxic injury models, respectively. BH4 levels were measured after injury. Cell viability, oxidative stress, apoptosis, RGC survival, retinal morphology, visual function, and NOS activity were assessed following BH4 supplementation.
Results
BH4 levels were significantly reduced in glutamate-injured R28 cells and NMDA-damaged retinas. BH4 supplementation improved cell survival, reduced oxidative stress, and attenuated apoptosis in injured R28 cells. In vivo, BH4 preserved RGC survival, alleviated retinal damage, and improved visual function after NMDA injury. Mechanistically, BH4 restored neuronal nitric oxide synthase (nNOS) coupling and activity, increased nitric oxide levels, re-established nitroso-redox homeostasis, and suppressed apoptotic signaling.
Conclusions
BH4 deficiency contributes to glutamate-induced retinal neurodegeneration by promoting nNOS uncoupling and nitroso-redox imbalance. Restoring BH4 levels protects against excitotoxic RGC damage, suggesting the BH4-nNOS axis as a potential therapeutic target for retinal neurodegeneration.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Eye Center of Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Hunan Key Laboratory of Ophthalmology, Changsha, Hunan, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- FuRong Laboratory, Changsha, Hunan, China.
Cite
APA
Fang, W., Meng, S., Wang, C., Feng, L., Zhao, Z., Dong, Q., Ding, L., & Xia, X. (2026). Tetrahydrobiopterin Supplementation Protects Retinal Ganglion Cells Against NMDA-Induced Excitotoxicity Through nNOS-Coupled Nitric Oxide Signaling. Investigative Ophthalmology & Visual Science, 67(13), 19. https://doi.org/10.1167/iovs.67.13.19
Vancouver
Fang W, Meng S, Wang C, Feng L, Zhao Z, Dong Q, et al. Tetrahydrobiopterin Supplementation Protects Retinal Ganglion Cells Against NMDA-Induced Excitotoxicity Through nNOS-Coupled Nitric Oxide Signaling. Investigative Ophthalmology & Visual Science. 2026;67(13):19. doi:10.1167/iovs.67.13.19
BibTeX
@article{Fang2026,
author = {Fang, Weizhou and Meng, Shuhan and Wang, Chao and Feng, Lemeng and Zhao, Zeyi and Dong, Qing and Ding, Lexi and Xia, Xiaobo},
title = {Tetrahydrobiopterin Supplementation Protects Retinal Ganglion Cells Against NMDA-Induced Excitotoxicity Through nNOS-Coupled Nitric Oxide Signaling},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
volume = {67},
number = {13},
pages = {19},
doi = {10.1167/iovs.67.13.19}
}
EUVIMED